Skip to main content
Equibles

Man Group plc

Position in MYGN — Myriad Genetics Inc

CIK 1637460 LONDON, X0
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,188,865
+$3,936,956 QoQ
Shares Held
908,733
+226.6% QoQ
Ownership
0.950%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 196 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Man Group plc holds $623,276,743 across 23 Diagnostics & Research names. MYGN ranks #10 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 1,349,523 $179,257,139
2 NTRA
Natera, Inc.
 406,753 $110,413,101
3 TMO
Thermo Fisher Scientific Inc.
 195,160 $97,845,417
4 DHR
Danaher Corp /De/
 428,118 $81,547,916
5 IQV
Iqvia Holdings Inc.
 295,679 $57,131,095
6 IDXX
Idexx Laboratories Inc /De
 51,382 $27,049,538
7 LH
Labcorp Holdings Inc.
 73,649 $20,621,720
8 MTD
Mettler Toledo International Inc/
 10,721 $13,696,184

All Filings in MYGN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,188,865 908,733
2026-03-31 $1,251,909 278,202
2025-12-31 $504,047 81,959
2025-06-30 $199,953 37,656
2025-03-31 $325,928 36,745
2024-12-31 $390,118 28,455
2022-06-30 $2,853,000 157,071
2022-03-31 $6,855,634 272,049
2021-12-31 $6,582,047 238,480
2021-09-30 $4,297,799 133,100
2021-06-30 $2,174,238 71,100